Open buy · week 6 · US stocks
Novavax slips 1.6% as a fresh 30-day high fails to hold into the weekly close
Our view last week
Novavax climbs 5.1% for a second straight weekly gain: price is back at the level already reached in the 10.4 area, and no session has turned it away yet, so for now the move continues. A rising ADX says the trend is gaining conviction, even as the weekly candle loses body. Novavax stock stays among the weekly buy signals for US stocks, 18.9% above entry: a swing trading case with elevated volatility, to be handled with discipline.
This week's summary
Novavax printed a fresh 30-day high in the 11.1 area this week, but the close did not confirm it: the stock slips 1.6% and ends near the week's low. A week ago price was climbing unopposed, now it has met its first obstacle. The structure holds, with a rising ADX and 5 higher lows on the daily chart. Novavax stock keeps its place among the weekly buy signals on US stocks, up 17% since entry: swing trading with wide swings.
IQS Phase
50
ordinary
Signal Strength
86
high · wide & volatile
Sizing
FULL
Ranking
#8 / 93
US stocks in progress
Trade P&L %
+17.00%
from signal to date, no stop loss
Novavax (NVAX) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 8th among the 93 Longs already running for US stocks in our ranking, with a signal strength of 86 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -2.65% · monthly -3.91%
NVAX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content